Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Dec 15;89(24):11973–11977. doi: 10.1073/pnas.89.24.11973

Borocaptate sodium: a potential boron delivery compound for boron neutron capture therapy evaluated in dogs with spontaneous intracranial tumors.

S L Kraft 1, P R Gavin 1, C E DeHaan 1, C W Leathers 1, W F Bauer 1, D L Miller 1, R V Dorn 3rd 1
PMCID: PMC50680  PMID: 1465427

Abstract

Borocaptate sodium (Na2B12H11SH) is a boron-carrying compound under consideration for use in boron neutron capture therapy. The biodistribution of boron from borocaptate sodium administration will partly determine boron neutron capture therapy efficacy and normal tissue radiation tolerance. The biodistribution of boron was determined in 30 dogs with spontaneous intracranial tumors at 2, 6, or 12 hr after intravenous borocaptate sodium infusion. Blood and tissue boron concentrations were measured using inductively coupled plasma atomic emission spectroscopy. Mean tumor boron concentration (mean +/- standard error) was 35.9 +/- 4.6 (n = 15), 22.5 +/- 6.0 (n = 9), and 7.0 +/- 1.1 micrograms of boron per g (n = 6) at 2, 6, and 12 hr, respectively, after borocaptate sodium infusion. Peritumor boron concentrations were elevated above that of normal brain in half of the dogs. Normal brain boron concentration (mean +/- standard error) was 4.0 +/- 0.5, 2.0 +/- 0.4, and 2.0 +/- 0.3 micrograms of boron per g at 2, 6, and 12 hr after infusion, respectively. Some cranial and systemic tissues, and blood, had high boron concentration relative to tumor tissue. Geometric dose sparing should partly offset these relatively high normal tissue and blood concentrations. Borocaptate sodium biodistribution is favorable because tumor boron concentrations of recommended magnitude for boron neutron capture therapy were obtained and there was a high tumor-to-normal brain boron concentration ratio.

Full text

PDF
11973

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe M., Amano K., Kitamura K., Ohta M., Tateishi J., Hatanaka H. Capillary permeability and boron distribution in ethylnitrosourea-induced rat glioma. Neurosurgery. 1988 Jan;22(1 Pt 1):23–31. doi: 10.1227/00006123-198801010-00004. [DOI] [PubMed] [Google Scholar]
  2. Abe M., Amano K., Kitamura K., Tateishi J., Hatanaka H. Boron distribution analysis by alpha-autoradiography. J Nucl Med. 1986 May;27(5):677–684. [PubMed] [Google Scholar]
  3. Barth R. F., Soloway A. H., Fairchild R. G. Boron neutron capture therapy for cancer. Sci Am. 1990 Oct;263(4):100-3, 106-7. doi: 10.1038/scientificamerican1090-100. [DOI] [PubMed] [Google Scholar]
  4. Barth R. F., Soloway A. H., Fairchild R. G. Boron neutron capture therapy of cancer. Cancer Res. 1990 Feb 15;50(4):1061–1070. [PubMed] [Google Scholar]
  5. Bauer W. F., Johnson D. A., Steele S. M., Messick K., Miller D. L., Propp W. A. Gross boron determination in biological samples by inductively coupled plasma-atomic emission spectroscopy. Strahlenther Onkol. 1989 Feb-Mar;165(2-3):176–179. [PubMed] [Google Scholar]
  6. Clendenon N. R., Barth R. F., Gordon W. A., Goodman J. H., Alam F., Staubus A. E., Boesel C. P., Yates A. J., Moeschberger M. L., Fairchild R. G. Boron neutron capture therapy of a rat glioma. Neurosurgery. 1990 Jan;26(1):47–55. doi: 10.1097/00006123-199001000-00007. [DOI] [PubMed] [Google Scholar]
  7. Davis L. W. Malignant glioma--a nemesis which requires clinical and basic investigation in radiation oncology. Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1355–1365. doi: 10.1016/0360-3016(89)90936-x. [DOI] [PubMed] [Google Scholar]
  8. Fairchild R. G., Bond V. P. Current status of 10B-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation. Int J Radiat Oncol Biol Phys. 1985 Apr;11(4):831–840. doi: 10.1016/0360-3016(85)90318-9. [DOI] [PubMed] [Google Scholar]
  9. Fairchild R. G., Kahl S. B., Laster B. H., Kalef-Ezra J., Popenoe E. A. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res. 1990 Aug 15;50(16):4860–4865. [PubMed] [Google Scholar]
  10. Finkel G. C., Poletti C. E., Fairchild R. G., Slatkin D. N., Sweet W. H. Distribution of 10B after infusion of Na210B12H11SH into a patient with malignant astrocytoma: implications for boron neutron capture therapy. Neurosurgery. 1989 Jan;24(1):6–11. doi: 10.1227/00006123-198901000-00002. [DOI] [PubMed] [Google Scholar]
  11. Gabel D., Foster S., Fairchild R. G. The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Radiat Res. 1987 Jul;111(1):14–25. [PubMed] [Google Scholar]
  12. Gavin P. R., Kraft S. L., Wendling L. R., Miller D. L. Canine spontaneous brain tumors--a large animal model for BNCT. Strahlenther Onkol. 1989 Feb-Mar;165(2-3):225–228. [PubMed] [Google Scholar]
  13. Joel D. D., Slatkin D. N., Micca P. L., Nawrocky M. M., Dubois T., Velez C. Uptake of boron into human gliomas of athymic mice and into syngeneic cerebral gliomas of rats after intracarotid infusion of sulfhydryl boranes. Basic Life Sci. 1989;50:325–332. doi: 10.1007/978-1-4684-5622-6_36. [DOI] [PubMed] [Google Scholar]
  14. Kitao K. A method for calculating the absorbed dose near interface from 10B(n, alpha)7Li reaction. Radiat Res. 1975 Feb;61(2):304–315. [PubMed] [Google Scholar]
  15. Soloway A. H., Hatanaka H., Davis M. A. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds. J Med Chem. 1967 Jul;10(4):714–717. doi: 10.1021/jm00316a042. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES